Clinical Trial Update: Macrophages in Smokers' Lung

View source ↗

Summary

A clinical trial investigating macrophages in smokers' lungs for COPD and emphysema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Snippet

Sponsor: Imperial College London | Conditions: Chronic Obstructive Pulmonary Disease, Emphysema | Status: WITHDRAWN